SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057091
Filing Date
2024-05-09
Accepted
2024-05-09 16:30:50
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avro-20240331.htm   iXBRL 10-Q 1800343
2 EX-31.1 avro-ex31_1.htm EX-31.1 14780
3 EX-32.1 avro-ex32_1.htm EX-32.1 9365
  Complete submission text file 0000950170-24-057091.txt   6232569

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT avro-20240331.xsd EX-101.SCH 1003477
67 EXTRACTED XBRL INSTANCE DOCUMENT avro-20240331_htm.xml XML 766391
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 24931239
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)